BIO-key International (BKYI) Stock Price, News & Analysis

Company Overview

BIO-key International, Inc. develops biometric identity and access management solutions designed to help organizations secure applications, devices and networks. Its offerings use fingerprint authentication and other authentication methods to provide alternatives or supplements to passwords, supporting secure access for employees, students, customers and other users.

The company’s products include biometric readers and related software, as well as its PortalGuard identity and access management platform. PortalGuard provides capabilities such as single sign-on, multifactor authentication, self-service password management and identity verification. BIO-key’s solutions can be deployed in cloud, on-premises or hybrid environments and are intended for use with enterprise, education, healthcare, government and other organizational systems.

BIO-key was founded in 1993 and is headquartered in Wall, New Jersey. The company markets its products directly and through partners to organizations in the United States and international markets. Michael DePasquale serves as the company’s chairman and chief executive officer.

Key Stats

• Today's Range: $1.63 to $2.14
• 50-Day Range: $1.79 to $4.77
• 52-Week Range: $1.63 to $19.70
• Volume: 179,208 shs
• Average Volume: 54,760 shs
• Market Capitalization: $2.58 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Reduce

BIO-key International Stock Analysis - MarketRank™

BIO-key International scored higher than 34% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Reduce

Consensus Rating

BIO-key International has received a consensus rating of Reduce. The company's average rating score is 1.50, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and 1 sell rating.

Amount of Analyst Coverage

BIO-key International has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for BIO-key International are expected to grow in the coming year, from ($1.62) to $0.22 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of BIO-key International is -0.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of BIO-key International is -0.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

BIO-key International has a P/B Ratio of 0.38. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.48% of the float of BIO-key International has been sold short.

Short Interest Ratio / Days to Cover

BIO-key International has a short interest ratio ("days to cover") of 0.53, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in BIO-key International has recently decreased by 39.13%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

BIO-key International does not currently pay a dividend.

Dividend Growth

BIO-key International does not have a long track record of dividend growth.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 0.38

News Sentiment

BIO-key International has a news sentiment score of 0.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.67 average news sentiment score of Technology companies.

News Coverage This Week

MarketBeat has tracked 6 news articles for BIO-key International this week, compared to 3 articles on an average week.

Search Interest

1 people have searched for BKYI on MarketBeat in the last 30 days.

MarketBeat Follows

1 people have added BIO-key International to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, BIO-key International insiders have not sold or bought any company stock.

Percentage Held by Insiders

4.00% of the stock of BIO-key International is held by insiders.

Percentage Held by Institutions

26.51% of the stock of BIO-key International is held by institutions.

Company Calendar

• Last Earnings: 8/13/2026
• Today: 9/26/2026
• Next Earnings (Estimated): 11/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Technology
• Industry: Software
• Sub-Industry: Systems Software
• Current Symbol: NASDAQ:BKYI
• CIK: 1019034
• Web: www.bio-key.com
• Phone: (732) 359-1100
• Fax: 732-359-1101
• Employees: 42
• Year Founded: 1993

Profitability

• EPS (Trailing Twelve Months): ($4.11)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$7.16 million
• Net Margins: -50.01%
• Pretax Margin: -87.79%
• Return on Equity: -67.31%
• Return on Assets: -40.28%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.26
• Quick Ratio: 1.14

Sales & Book Value

• Annual Sales: $6.09 million
• Price / Sales: 0.42
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $4.71 per share
• Price / Book: 0.38

Miscellaneous

• Outstanding Shares: 1,440,000
• Free Float: 1,379,000
• Market Cap: $2.58 million
• Optionable: No Data
• Beta: 0.40